Back to Trades
Total Value
$49.4K
Net $26.1K sold
Filing Date
Jun 25, 2026
1 transaction
Sales
$26.1K
1 transaction
Trade Summary
On Jun 23, 2026, Doyle Mittie, Insider, sold $49.4K of Avalo Therapeutics, Inc. (AVTX) across 1 transaction. The filing covers Common Stock and reflects net selling of $26.1K. Reported prices ranged from $8.04 to $18.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Avalo Therapeutics, Inc.
- Ticker Symbol
- AVTX
- CIK
- 0001534120
Insider Information
- Name
- Doyle Mittie
- Role
- Insider
- Location
- WAYNE, PA
Filing Details
- Filing Date
- Jun 25, 2026
- Transaction Date
- Jun 23, 2026
- Accession Number
- 0001918845-26-000020
- Form Type
- 4
- Net Trading Amount
- -$26.1K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Common Stock | 1,450 | $8.04 | Exercise | $11.7K |
| Jun 23, 2026 | Common Stock | 1,450 | $18.00 | Sale | $26.1K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | AVTX derivative | 1,450 | $8.04 | Exercise | $11.7K |
Want live alerts when Doyle Mittie trades again?
Download Insider Trades to track AVTX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.
- (F2)The stock option vests twenty-five percent (25%) on January 28, 2026 and the remainder will vest in equal monthly installments over the following three (3) years, subject to the Reporting Person's continued service on each such vesting date.